Literature DB >> 25990271

Deoxycholic acid inhibited proliferation and induced apoptosis and necrosis by regulating the activity of transcription factors in rat pancreatic acinar cell line AR42J.

Guixin Zhang1, Jingwen Zhang2,3, Dong Shang4, Bing Qi5, Hailong Chen6.   

Abstract

The objective of this study is to investigate the effect of deoxycholic acid (DCA) on rat pancreatic acinar cell line AR42J and the functional mechanisms of DCA on AR42J cells. AR42J cells were treated with various concentrations of DCA for 24 h and also treated with 0.4 mmol/L DCA for multiple times, and then, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was performed to detect the AR42J cell survival rate. Flow cytometric was used to detect the cell apoptosis and necrosis in AR42J cells treated with 0.4 mmol/L and 0.8 mmol/L DCA. The cells treated with phosphate buffer saline (PBS) were served as control. In addition, the DNA-binding activity assays of transcription factors (TFs) in nuclear proteins of cells treated with DCA were determined using Panomics Procarta Transcription Factor Assay Kit. The relative survival rates were markedly decreased (P < 0.05) in a dose- and time-dependent manner. Compared with control group, the cell apoptosis and necrosis ratio were both significantly elevated in 0.4 mmol/L DCA and 0.8 mmol/L DCA groups (P < 0.01). A significant increase (P < 0.05) in the activity of transcription factor 2 (ATF2), interferon-stimulated response element (ISRE), NKX-2.5, androgen receptor (AR), p53, and hypoxia-inducible factor-1 (HIF-1) was observed, and the activity of peroxisome proliferator-activated receptor (PPAR), activator protein 1 (AP1), and E2F1 was reduced (P < 0.05). In conclusion, DCA inhibited proliferation and induced apoptosis and necrosis in AR42J cells. The expression changes of related genes regulated by TFs might be the molecular mechanism of AR42J cell injury.

Entities:  

Keywords:  Cell injury; Deoxycholic acid; Rat pancreatic acinar cell; Transcription factors

Mesh:

Substances:

Year:  2015        PMID: 25990271     DOI: 10.1007/s11626-015-9907-x

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  34 in total

Review 1.  Transcriptional regulation by p53: one protein, many possibilities.

Authors:  O Laptenko; C Prives
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

2.  Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2.

Authors:  S J Kim; S Wagner; F Liu; M A O'Reilly; P D Robbins; M R Green
Journal:  Nature       Date:  1992-07-23       Impact factor: 49.962

Review 3.  Blinded by the Light: The Growing Complexity of p53.

Authors:  Karen H Vousden; Carol Prives
Journal:  Cell       Date:  2009-05-01       Impact factor: 41.582

4.  Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis.

Authors:  Tzipora Shoshani; Alexander Faerman; Igor Mett; Elena Zelin; Tamar Tenne; Svetlana Gorodin; Yana Moshel; Shlomo Elbaz; Andrei Budanov; Ayelet Chajut; Hagar Kalinski; Iris Kamer; Ada Rozen; Orna Mor; Eli Keshet; Dena Leshkowitz; Paz Einat; Rami Skaliter; Elena Feinstein
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

5.  In vitro studies investigating the effect of subcutaneous phosphatidylcholine injections in the 3T3-L1 adipocyte model: lipolysis or lipid dissolution?

Authors:  Silvan M Klein; Stephan Schreml; Michael Nerlich; Lukas Prantl
Journal:  Plast Reconstr Surg       Date:  2009-08       Impact factor: 4.730

6.  Tumor necrosis factor alpha gene regulation in activated T cells involves ATF-2/Jun and NFATp.

Authors:  E Y Tsai; J Jain; P A Pesavento; A Rao; A E Goldfeld
Journal:  Mol Cell Biol       Date:  1996-02       Impact factor: 4.272

Review 7.  Acute pancreatitis.

Authors:  Jean-Louis Frossard; Michael L Steer; Catherine M Pastor
Journal:  Lancet       Date:  2008-01-12       Impact factor: 79.321

Review 8.  The role of protein kinase C isoenzymes in the regulation of cell proliferation and differentiation.

Authors:  M J Clemens; I Trayner; J Menaya
Journal:  J Cell Sci       Date:  1992-12       Impact factor: 5.285

9.  ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents.

Authors:  H van Dam; D Wilhelm; I Herr; A Steffen; P Herrlich; P Angel
Journal:  EMBO J       Date:  1995-04-18       Impact factor: 11.598

10.  Elevated Deoxycholic Acid and Idiopathic Recurrent Acute Pancreatitis: A Case Report With 48 Months of Follow-up.

Authors:  Gregory A Plotnikoff
Journal:  Glob Adv Health Med       Date:  2014-05
View more
  4 in total

1.  The Detailed Comparison of Cell Death Detected by Annexin V-PI Counterstain Using Fluorescence Microscope, Flow Cytometry and Automated Cell Counter in Mammalian and Microalgae Cells.

Authors:  Emine Koç; Selcen Çelik-Uzuner; Uğur Uzuner; Ramazan Çakmak
Journal:  J Fluoresc       Date:  2018-10-21       Impact factor: 2.217

2.  Phosphatidylcholine causes adipocyte-specific lipolysis and apoptosis in adipose and muscle tissues.

Authors:  Tae Woo Jung; Taekwang Park; Jinwoo Park; Uiseok Kim; Hyun Dong Je; Hyeong-Dong Kim; Seong-Wan Cho; A M Abd El-Aty; Jin-Ho Song; Hyoung-Chun Kim; Yong Kyoo Shin; Ji Hoon Jeong
Journal:  PLoS One       Date:  2019-04-08       Impact factor: 3.240

Review 3.  The activating transcription factor 2: an influencer of cancer progression.

Authors:  Kerstin Huebner; Jan Procházka; Ana C Monteiro; Vijayalakshmi Mahadevan; Regine Schneider-Stock
Journal:  Mutagenesis       Date:  2019-12-19       Impact factor: 3.000

4.  Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer.

Authors:  Athina Giannoudis; Mohammed Imad Malki; Bharath Rudraraju; Hisham Mohhamed; Suraj Menon; Triantafillos Liloglou; Simak Ali; Jason S Carroll; Carlo Palmieri
Journal:  Breast Cancer Res       Date:  2020-11-16       Impact factor: 6.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.